Viewing Study NCT05244304


Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2025-12-24 @ 9:12 PM
Study NCT ID: NCT05244304
Status: COMPLETED
Last Update Posted: 2025-10-31
First Post: 2022-01-20
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease
Sponsor: Belite Bio, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module